
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.
All lifecos will benefit in a rising interest rate environment. Recent earnings reported were not that fantastic and thinks this has to do with the historic volatility of their earnings. Doesn’t think the market is giving the lifecos the benefit of the doubt, but there is no question that this is a good way to play a rising rate environment.
Metrlife (MET-N) or Manulife (MFC-T). Which has a better upside? All things being equal, and if she liked both of them equally, she would prefer the Canadian stock because of the currency. They have good business in Asia which, longer-term, is going to be a good growth area. Lower interest rates are going to be a headwind, but that is a non-core issue. Valuation is not onerous and it provides an attractive yield.
If interest rates rise, this will work. If they don’t, it will stay in the same range. Excellent company. The company has been de-risked to such an extent that the increase in equities hasn’t really driven the company to a higher level. Because of this, he prefers Sun Life (SLF-T). If you have a longer-term outlook, this is fine.
He has an issue with the low interest rate environment and insurance companies. But they have brought their leverage down and that has helped them. They would like to do acquisitions, but the big ones are few and far between. They can grow their ROE, but you need to still see less leverage on their balance sheet. He prefers SLF-T where they have the asset management business.
This is under a lot of pressure. The interest rate scenario is obviously not positive for insurance companies. The CEO wants to get the company up to $4 billion in core revenue, and right now they are at about $3 billion. They are going to need a lot of things to go right in order to get the last billion dollars squeezed out. He is right on the edge about being nervous in owning this name. 50% of their revenues are coming in from abroad including the US and Asia. They need a better market and they need rates to go up for them to do much better from here.
October to December and February to May are periods of seasonal strength. It tends to go lower in January. Hang in there. Buy on weakness until part way into February. The trend is mixed, near its 20 day moving average and it is outperforming the financial services sector and probably the Canadian market as well. It is getting lined up.
This will be negatively impacted on the spreads by the lower interest rates, but probably offsetting it is 275 points upwards on markets, and maybe markets continuing net higher over the year. He likes this company. Has really good Asian growth. Has pulled back lately with the softness in Canadian financials. Has a $25 target.